DE60012196T2 - Verfahren zur Herstellung von Naphthyridin-3-carbonsäurederivaten - Google Patents

Verfahren zur Herstellung von Naphthyridin-3-carbonsäurederivaten Download PDF

Info

Publication number
DE60012196T2
DE60012196T2 DE60012196T DE60012196T DE60012196T2 DE 60012196 T2 DE60012196 T2 DE 60012196T2 DE 60012196 T DE60012196 T DE 60012196T DE 60012196 T DE60012196 T DE 60012196T DE 60012196 T2 DE60012196 T2 DE 60012196T2
Authority
DE
Germany
Prior art keywords
formula
compound
naphthyridine
aminomethyl
base
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60012196T
Other languages
German (de)
English (en)
Other versions
DE60012196D1 (de
Inventor
Sungwook Yusong-gu CHO
Hoon Yusong-gu CHOI
David John Tonbridge HAYLER
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LG Chem Ltd
Original Assignee
LG Life Sciences Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LG Life Sciences Ltd filed Critical LG Life Sciences Ltd
Application granted granted Critical
Publication of DE60012196D1 publication Critical patent/DE60012196D1/de
Publication of DE60012196T2 publication Critical patent/DE60012196T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE60012196T 1999-09-03 2000-09-01 Verfahren zur Herstellung von Naphthyridin-3-carbonsäurederivaten Expired - Lifetime DE60012196T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9920917 1999-09-03
GBGB9920917.3A GB9920917D0 (en) 1999-09-03 1999-09-03 Novel process
PCT/GB2000/003366 WO2001018002A1 (en) 1999-09-03 2000-09-01 Process for production of naphthyridine-3-carboxylic acid derivatives

Publications (2)

Publication Number Publication Date
DE60012196D1 DE60012196D1 (de) 2004-08-19
DE60012196T2 true DE60012196T2 (de) 2005-08-18

Family

ID=10860353

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60012196T Expired - Lifetime DE60012196T2 (de) 1999-09-03 2000-09-01 Verfahren zur Herstellung von Naphthyridin-3-carbonsäurederivaten

Country Status (23)

Country Link
US (1) US7232907B2 (enExample)
EP (1) EP1214321B1 (enExample)
JP (1) JP4208464B2 (enExample)
KR (1) KR100724311B1 (enExample)
CN (1) CN1275963C (enExample)
AR (1) AR029002A1 (enExample)
AT (1) ATE271050T1 (enExample)
AU (1) AU773722B2 (enExample)
BR (1) BRPI0013751B8 (enExample)
CA (1) CA2383753C (enExample)
CO (1) CO5470281A1 (enExample)
DE (1) DE60012196T2 (enExample)
DK (1) DK1214321T3 (enExample)
ES (1) ES2223574T3 (enExample)
GB (1) GB9920917D0 (enExample)
HK (1) HK1047093B (enExample)
MX (1) MXPA02002355A (enExample)
MY (1) MY125309A (enExample)
PT (1) PT1214321E (enExample)
SI (1) SI1214321T1 (enExample)
TW (1) TWI274753B (enExample)
WO (1) WO2001018002A1 (enExample)
ZA (1) ZA200201781B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2281817C (en) * 1999-06-29 2008-07-29 Smithkline Beecham Corporation Methods of use of fluoroquinolone compounds against maxillary sinus pathogenic bacteria
GB9920919D0 (en) * 1999-09-03 1999-11-10 Sb Pharmco Inc Novel compound
GB9920917D0 (en) 1999-09-03 1999-11-10 Sb Pharmco Inc Novel process
WO2003011450A1 (en) 2001-08-02 2003-02-13 Lg Life Sciences Limited Processes for the production of amino-protected derivatives of 4-aminomethylene-pyrrolidin-3-one and/or 4-aminomethylene-pyrrolidin-3-alkoxyimino derivatives and/or gemifloxacin or a salt thereof
KR100517638B1 (ko) * 2002-04-08 2005-09-28 주식회사 엘지생명과학 게미플록사신 산염의 새로운 제조방법
KR100653334B1 (ko) * 2003-03-07 2006-12-04 주식회사 엘지생명과학 4-아미노메틸-3-알콕시이미노피롤리딘 메탄설폰산염의 신규한 제조 방법
WO2006134431A1 (en) * 2005-05-03 2006-12-21 Ranbaxy Laboratories Limited Formate salt of gemifloxacin
EP2159225A1 (en) 2005-06-15 2010-03-03 Hetero Drugs Limited Gemifloxacin process and polymorphs
US20100076193A1 (en) * 2006-10-31 2010-03-25 Chandrasekaran Ramasubbu process for the preparation of gemifloxacin

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57134482A (en) 1981-02-13 1982-08-19 Dainippon Pharmaceut Co Ltd 1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-1,8- naphthyridine-3-carboxylic acid-3/2 hydrate and its preparation
IN162769B (enExample) 1984-11-13 1988-07-09 Kyorin Seiyaku Kk
NZ222047A (en) 1986-10-08 1991-01-29 Bristol Myers Co Quinoline - or naphthyridine - carboxylic acid anti-bacterial agents
JPH01100165A (ja) 1987-10-13 1989-04-18 Shionogi & Co Ltd オキシムまたはヒドロキシアミン誘導体系抗菌剤
US4920120A (en) 1988-01-25 1990-04-24 Warner-Lambert Company Antibacterial agents
JPH0356479A (ja) 1989-07-24 1991-03-12 Takeshi Yokota 水溶性キノロン誘導体のｐ‐トルエンスルホン酸塩
IE66202B1 (en) 1989-08-16 1995-12-13 Pfizer Azabicyclo quinolone carboxylic acids
US5137892A (en) 1990-12-12 1992-08-11 Abbott Laboratories Quinoline, naphthyridine and pyridobenzoxazine derivatives
EP0541086A1 (en) 1991-11-08 1993-05-12 Kaken Pharmaceutical Co., Ltd. Antibacterial 6-fluoro-quinolones having an oxime group on the substituent in position 7
JPH0673056A (ja) 1992-08-26 1994-03-15 Kaken Pharmaceut Co Ltd キノリンカルボン酸誘導体およびその塩
DK0688772T3 (da) * 1994-06-16 1999-11-01 Lg Chemical Ltd Quinolincarboxylsyrederivater med 7-(4-aminomethyl-3-oxim)-pyrrolidinsubstituenter og fremgangsmåde til deres fremstilling
US5776944A (en) * 1994-06-16 1998-07-07 Lg Chemical Ltd. 7-(4-aminomethyl-3-methyloxyiminopyrroplidin-1-yl)-1-cyclopropyl-6-flu oro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid and the process for the preparation thereof
JP3449658B2 (ja) 1994-12-21 2003-09-22 杏林製薬株式会社 安定性に優れた８−アルコキシキノロンカルボン酸水和物並びにその製造方法
CA2223404C (en) 1995-06-06 2001-01-16 Thomas A. Morris Novel crystal form of anhydrous 7-(¬1.alpha., 5.alpha., 6.alpha.|-6-amino-3-azabicyclo¬3.1.0|hex-3-yl)-6-fluoro-1-(2,4-difluorophenyl)-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid, methanesulfonic acid salt
RU2140910C1 (ru) 1995-08-11 1999-11-10 Пфайзер Инк. Тригидрат метансульфоната (1s,2s)-1-(4-гидроксифенил)-2-(4-гидрокси-4- фенилпиперидин-1-ил)-1-пропанола
BR9708336A (pt) 1996-03-29 1999-08-03 Smithkline Beecham Corp Diidrato de eprosartan e processo para sua produção e formulação
MA24500A1 (fr) * 1997-03-21 1998-10-01 Lg Life Sciences Ltd Derive du sel d'acide carboxylique de naphthyridine .
KR100286874B1 (ko) * 1998-03-04 2001-04-16 성재갑 보호된 4-아미노메틸-피롤리딘-3-온의 제조방법
JP2002516308A (ja) 1998-05-29 2002-06-04 ファルマシア・アンド・アップジョン・カンパニー ３−［（１’−ｎ−メチルアミノ）エチル−ｎ−ベンジル］ピロリジンモノメタンスルホネート
GB9820405D0 (en) 1998-09-18 1998-11-11 Smithkline Beecham Plc Process
PT1223935E (pt) 1999-06-29 2008-04-03 Lg Life Sciences Ltd Utilização de compostos de gemifloxacina contra bactérias
AU6947900A (en) 1999-09-01 2001-03-26 Smithkline Beecham Corporation Methods of use of fluoroquinolone compounds against bacteria
GB9920917D0 (en) 1999-09-03 1999-11-10 Sb Pharmco Inc Novel process
GB9920919D0 (en) 1999-09-03 1999-11-10 Sb Pharmco Inc Novel compound
AU7709400A (en) 1999-09-22 2001-04-24 Smithkline Beecham Corporation Methods of use of fluoroquinolone compounds against bacteria
KR20010091379A (ko) 2000-03-15 2001-10-23 성재갑 7-(4-아미노메틸-3-옥심)피롤리딘 치환체를 갖는 퀴놀린카르복실산 유도체의 신규 제조방법
KR20020018560A (ko) 2000-09-01 2002-03-08 성재갑 3-아미노메틸-4-ｚ-메톡시이미노피롤리딘의 신규 제조방법

Also Published As

Publication number Publication date
MXPA02002355A (es) 2004-07-16
GB9920917D0 (en) 1999-11-10
CA2383753A1 (en) 2001-03-15
KR100724311B1 (ko) 2007-06-04
TWI274753B (en) 2007-03-01
DK1214321T3 (da) 2004-10-25
CN1377350A (zh) 2002-10-30
ATE271050T1 (de) 2004-07-15
AU773722B2 (en) 2004-06-03
EP1214321A1 (en) 2002-06-19
CA2383753C (en) 2011-06-28
PT1214321E (pt) 2004-10-29
ES2223574T3 (es) 2005-03-01
EP1214321B1 (en) 2004-07-14
HK1047093A1 (en) 2003-02-07
JP2003508532A (ja) 2003-03-04
JP4208464B2 (ja) 2009-01-14
ZA200201781B (en) 2003-06-25
BR0013751A (pt) 2002-05-07
KR20020041421A (ko) 2002-06-01
SI1214321T1 (en) 2004-12-31
US7232907B2 (en) 2007-06-19
US20050176961A1 (en) 2005-08-11
HK1047093B (en) 2005-05-27
BR0013751B1 (pt) 2013-02-05
CO5470281A1 (es) 2004-12-30
AU7019700A (en) 2001-04-10
WO2001018002A1 (en) 2001-03-15
DE60012196D1 (de) 2004-08-19
BRPI0013751B8 (pt) 2021-05-25
AR029002A1 (es) 2003-06-04
MY125309A (en) 2006-07-31
CN1275963C (zh) 2006-09-20

Similar Documents

Publication Publication Date Title
DE69213720T2 (de) VERFAHREN ZUR HERSTELLUNG VON IMIDAZO (4,5-c) CHINOLIN-4-AMINEN
DE69625712T2 (de) Verfahren zur herstellung von tetrahydroimidazochinolinaminen
DE69108920T2 (de) Verfahren zur herstellung von imidazo[4,5-c]chinolin-4-aminen.
DE69925150T2 (de) Naphthyridin-Verbindungen und ihre Azaisosteren Analoga als antibakterielle Mittel
DE69928952T2 (de) Chinolin-derivate und ihre verwendung als antibakterielle wirkstoffe
DE60305903T2 (de) Tropanderivative als ccr5-modulatoren
DE60012196T2 (de) Verfahren zur Herstellung von Naphthyridin-3-carbonsäurederivaten
EP0264081A2 (de) Oxadiazolylalkylpurin-Derivate, ihre Herstellung und ihre Verwendung in pharmazeutischen Mitteln
DE60012028T2 (de) Intermediate für die Herstellung von Chinoloncarbonsäurederivaten
DE68915310T2 (de) Verfahren zur Herstellung von enantiomerischen homogenen Aminopyrrolidinyl-naphthyridin- und Quinoloncarbonsäuren.
DE69228307T2 (de) Imidazo(1,2-c)chinazolinderivate als antihypertensive und antidysurie
DE602004009962T2 (de) Verfahren zur herstellung von substituierten 5-aminopyrazoloä4,3-eü-1,2,4-triazoloä1,5-cüpyrimidinen
DE69328701T2 (de) Diazabicycloderivate als 5-HT3-Antagonisten
DE2819873A1 (de) N-phenyl-n-(4-piperidinyl)-amide, verfahren zu deren herstellung und deren verwendung als analgetika
DE2748258A1 (de) Verfahren und zwischenprodukte zum dephthaloylieren von phthalimidoazetidinonen
DE69427978T2 (de) Zwischenprodukt zur verwendung in der synthese und verfahren zur herstellung eines aminopiperazinderivates
DE69514512T2 (de) Verfahren zur herstellung von benzopyranderivaten
CH638516A5 (en) Process for preparing substituted aminoquinazoline derivatives
DE69719210T2 (de) Verfahren zur herstellung von 2-amino-2-imidazolinen, guanidinen, und 2-amino-3,4,5,6-tetrahydropyrimidinen
DE69012407T2 (de) Imidazobenzodiazepine und ihre Salze, Verfahren zur Herstellung, Verwendung als Arzneimittel und diese Substanzen enthaltende Zusammensetzungen.
DD296926A5 (de) Neue pyridobenzoindolderivate, ihre herstellung und die sie enthaltenden zusammensetzungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition